Matt Luther, MD MSCI

@drjmluther.bsky.social

Nephrologist, Hypertension specialist, Physician-scientist.

Aaand it’s official, we have a new antihypertensive class!!!! 🎉🍾🎊 I like this RCT design in particular because it was open to both uncontrolled not-yet-resistant AND resistant hypertensive patients, opening to door to prescribe it as an earlier line agent www.nejm.org/doi/full/10....

Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM

Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...

nejm.org

Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures. #KidneyMonth2025 #RareDisease #genetics

rFSGS Initiative@rfsgsinitiative.bsky.social · last yr.

Building a biobank is key to finding new treatments for Recurrent Focal Segmental Glomerulosclerosis. If you or someone you know has #rFSGS and you want to learn how you can help by providing a biosample, email mb5150@cumc.columbia.edu. #KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph